Literature DB >> 23749896

Unexpected alteration of β-catenin and c-KIT expression by 5-FU and docetaxel in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.

Claudia Umbreit1, Christoph Aderhold, Anne Faber, Jörg Ulrich Sommer, Alexander Sauter, Ralf-Dieter Hofheinz, Jens Stern-Sträter, Karl Hoermann, Johannes David Schultz.   

Abstract

BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is the sixth most common type of cancer worldwide. In several tumour entities, the tyrosine kinase receptor c-KIT is associated with tumour transformation in the epithelial tissue in cases of aberrant expression. Furthermore, tumour development and dissemination are a result of dysregulated cellular pathways such as the WNT/β-catenin pathway. β-Catenin is a multifunctional protein within the canonical WNT signalling pathway and a pivotal factor for the stabilization of cell-cell interactions. In malignant tissues, β-catenin triggers tumour proliferation and progression. The aim of this study is to investigate the expression patterns of c-KIT and β-catenin in human papillomavirus-negative and p16-positive SCC and to evaluate the chemosensitivity of the tumour cells to the chemotherapeutical agents docetaxel and 5-fluorouracil (5-FU).
MATERIALS AND METHODS: We incubated the tumour cell lines with docetaxel (5 μmol/ml) and 5-FU (1 μmol/ml) and detected β-catenin and c-KIT by immunohistochemistry and enzyme-linked immunosorbent assay (ELISA) after 48, 72, 120, 192 and 240 h.
RESULTS: We found a reliable trend towards decreased β-catenin expression levels in p16-positive and p16-negative tumour cell lines when incubated with docetaxel, in addition to induced apoptotic effect. At best, 5-FU had a slight influence on the alteration of the expression of β-catenin. Dose escalation of docetaxel and 5-FU had no statistically significant effect on the expression of β-catenin or c-KIT. In HPV-negative HNSCC, a reduced expression level of β-catenin and c-KIT was detected in an incubation period-dependent manner. p16-transformed SCC (CERV196) cells were characterized by a reduced susceptibility to docetaxel induced alteration of β-catenin expression.
CONCLUSION: We were unable to confirm the clinically-substantiated increased chemosensitivity of p16-positive tumour cells in vitro. Extended studies and clinical trials are needed to investigate these findings further in HPV-associated HNSCC.

Entities:  

Keywords:  5-FU; c-KIT; docetaxel; epithelial mesenchymal transition (EMT); extracellular matrix; head and neck squamous cell carcinoma; human papillomavirus (HPV); protein tyrosine kinase; β-catenin

Mesh:

Substances:

Year:  2013        PMID: 23749896

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  MicroRNA-638 inhibits the progression of breast cancer through targeting HOXA9 and suppressing Wnt/β-cadherin pathway.

Authors:  Qian Xu; Qianqian Zhang; Mengli Dong; Yuan Yu
Journal:  World J Surg Oncol       Date:  2021-08-20       Impact factor: 2.754

2.  Secreted frizzled‑related protein 2 is epigenetically silenced and functions as a tumor suppressor in oral squamous cell carcinoma.

Authors:  Can Xiao; Lili Wang; Lifang Zhu; Chenping Zhang; Jianhua Zhou
Journal:  Mol Med Rep       Date:  2014-09-05       Impact factor: 2.952

3.  MicroRNA-182 downregulates Wnt/β-catenin signaling, inhibits proliferation, and promotes apoptosis in human osteosarcoma cells by targeting HOXA9.

Authors:  Zi-Feng Zhang; Yong-Jian Wang; Shao-Hua Fan; Shi-Xin Du; Xue-Dong Li; Dong-Mei Wu; Jun Lu; Yuan-Lin Zheng
Journal:  Oncotarget       Date:  2017-09-22

4.  Lapatinib-induced mesenchymal-epithelial transition in squamous cell carcinoma cells correlates with unexpected alteration of β-catenin expression.

Authors:  Claudia Umbreit; Philipp Erben; Anne Faber; Ralf-Dieter Hofheinz; Johannes David Schultz; Karl Hoermann; Angela Wenzel
Journal:  Oncol Lett       Date:  2016-03-01       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.